Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
74
0.920
Why?
Bone Neoplasms
2
2023
183
0.830
Why?
Phenylthiohydantoin
1
2016
2
0.560
Why?
Warfarin
1
2016
86
0.510
Why?
Anticoagulants
1
2016
253
0.450
Why?
Thrombosis
1
2016
248
0.440
Why?
Ketoconazole
1
2010
17
0.370
Why?
Androgen Antagonists
1
2010
11
0.370
Why?
Carcinoma, Renal Cell
1
2011
105
0.350
Why?
Sulfonamides
1
2011
128
0.350
Why?
Proton Pump Inhibitors
1
2010
85
0.350
Why?
Pyrimidines
1
2011
193
0.340
Why?
Kidney Neoplasms
1
2011
176
0.330
Why?
Protein Kinase Inhibitors
1
2011
206
0.330
Why?
Antineoplastic Agents
1
2016
1186
0.300
Why?
Prostatic Neoplasms
1
2010
394
0.280
Why?
Drug Interactions
2
2016
208
0.220
Why?
Phthalazines
1
2022
20
0.210
Why?
Piperazines
1
2022
118
0.190
Why?
Indoles
1
2022
278
0.170
Why?
Retrospective Studies
3
2023
6134
0.140
Why?
Prospective Studies
1
2023
2379
0.140
Why?
Nitriles
1
2016
54
0.140
Why?
Benzamides
1
2016
51
0.140
Why?
Humans
6
2023
50208
0.130
Why?
Male
4
2022
25399
0.110
Why?
Controlled Clinical Trials as Topic
1
2011
21
0.100
Why?
Clinical Trials, Phase III as Topic
1
2011
43
0.090
Why?
Indazoles
1
2011
46
0.090
Why?
Prostate-Specific Antigen
1
2010
47
0.090
Why?
Drug Resistance
1
2010
64
0.090
Why?
Treatment Outcome
2
2011
5155
0.090
Why?
Diphosphonates
1
2011
90
0.090
Why?
Middle Aged
3
2016
12206
0.090
Why?
Imidazoles
1
2011
128
0.090
Why?
Disease-Free Survival
1
2010
454
0.080
Why?
Gastrointestinal Diseases
1
2010
126
0.080
Why?
Drug Therapy, Combination
1
2010
381
0.080
Why?
Acute Kidney Injury
1
2011
285
0.070
Why?
Aged, 80 and over
2
2011
3154
0.070
Why?
Aged
2
2011
9405
0.040
Why?
Animals
1
2011
13246
0.030
Why?
Creatinine
1
2011
141
0.020
Why?
Incidence
1
2011
1006
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1378
0.020
Why?
Time Factors
1
2011
2922
0.010
Why?
Neoplasms
1
2011
1249
0.010
Why?
Adult
1
2011
13324
0.010
Why?
Female
1
2011
26635
0.010
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description